Fabry International Network

Fabry affects us - but not our ability to smile!

 
The following Q&A cannot be hold FIN acountable.
If there is a question that you do not see answered, contact you local Genzyme rep or contact FIN

Supply Q&A - Genzyme.



Following feedback from FIN and the community, Genzyme has developed Frequently Asked Questions Q&A for the Fabry community in order to address questions regarding the current situation on global Fabrazyme® allocations and manufacturing. Fabry patient groups are encouraged to contact their local Genzyme representative, to discuss translation of this document and to answer questions about Fabrazyme® availability in your country.

Patients should always consult with their treating physician for the latest information.


Genzyme Fabrazyme® (agalsidase beta) Supply Update
Frequently Asked Questions
October 3, 2011